Common Stock (Details Textual) (USD $)
|
1 Months Ended | 3 Months Ended | 4 Months Ended | 81 Months Ended | 1 Months Ended | 3 Months Ended | 81 Months Ended | ||
---|---|---|---|---|---|---|---|---|---|
Apr. 01, 2013
|
Mar. 31, 2013
Plans
|
May 07, 2013
|
Mar. 31, 2013
Plans
|
Apr. 29, 2013
Market Issuance Sales Agreement [Member]
|
Mar. 31, 2013
Market Issuance Sales Agreement [Member]
|
Apr. 01, 2013
Market Issuance Sales Agreement [Member]
|
Mar. 31, 2013
Market Issuance Sales Agreement [Member]
|
Mar. 31, 2013
Market Issuance Sales Agreement [Member]
|
|
Common Stock (Textual) [Abstract] | |||||||||
Public offering of Common Stock, shares | 3,400,000 | 1,565,101 | 1,800,000 | ||||||
Net proceeds from public offering of Common Stock | $ 11,690,000 | $ 40,743,000 | $ 45,000,000 | $ 11,100,000 | $ 700,000 | $ 11,800,000 | $ 18,100,000 | ||
Utilization amount | 30,000,000 | ||||||||
Common Stock (Additional Textual) [Abstract] | |||||||||
Number of equity compensation plans | 2 | 2 | |||||||
Stock-based compensation expense related to all unvested stock option | 10,700,000 | 10,700,000 | |||||||
Stock-based compensation weighted-average vesting period | 1 year 10 months 24 days | ||||||||
Issuance of common stock | 8,415 | ||||||||
Issued warrants to purchase common stock | 18,724 | ||||||||
Warrant exercise price | 4.97 | 4.97 | |||||||
Proceeds from common stock included in other current assets | $ 700,000 |